NASDAQ

Nomad Power Solutions, Inc. (NMAD)

319 Thanks from members

Nomad Power Solutions (NMAD), formerly Lixte Biotechnology, exhibits a high-risk operational transformation with widened Q2 2026 losses, zero revenue, and a strategic shift into AI energy infrastructure following its recent acquisition.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →